Immunoglobulin A: magic bullet or Trojan horse?

Area of Science:

• Immunology
• Cell Biology

Background:

• Neutrophils are key immune cells involved in pathogen defense through phagocytosis, degranulation, and neutrophil extracellular trap release.
• Antibody opsonization, particularly with Immunoglobulin A (IgA), enhances neutrophil pathogen recognition via Fc receptors.
• IgA is abundant at mucosal sites and plays critical roles in maintaining homeostasis and immunity.

Purpose of the Study:

• To review the complex interplay between IgA, its receptor Fc-alpha Receptor I (FcαRI), and neutrophils.
• To explore the therapeutic potential of modulating this interaction for autoimmune diseases and cancer treatment.

Main Methods:

• This review synthesizes existing research on IgA-FcαRI interactions with neutrophils.
• Analysis of how FcαRI crosslinking by IgA-immune complexes influences neutrophil activation and effector functions.

Main Results:

• IgA-immune complexes binding to FcαRI can strongly activate neutrophils, promoting inflammation and tissue damage in autoimmune diseases.
• Targeting FcαRI can harness potent neutrophil functions for effective cancer immunotherapy.

Conclusions:

• Modulating the IgA-FcαRI interaction offers a promising therapeutic strategy for various diseases.
• Interfering with or promoting this interaction could lead to novel treatments for autoimmune conditions and cancer.